FDA grants accelerated approval for Sprycel (dasatinib) (News-Medical-Net)
FDA grants accelerated approval for Sprycel (dasatinib), a new oral treatment for patients with chronic myeloid leukemia (CML),

FDA Grants Swift Approval to New Leukemia Drug (HealthDay via Yahoo! News)
THURSDAY, June 29 (HealthDay News) -- U.S. regulators gave accelerated approval Wednesday to a new targeted therapy to treat people with chronic myeloid leukemia (CML).

FDA Gives Rapid Approval for a New Treatment for a Rare Type of Leukemia (Kansas City InfoZine)
The Food and Drug Administration (FDA) granted accelerated approval for Sprycel (dasatinib), a new oral treatment for patients with chronic myeloid leukemia (CML), a rare cancer characterized by the uncontrolled growth of white blood cells.